Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31No description of principal activity13truefalse2023-01-01false12false 10963006 2023-01-01 2023-12-31 10963006 2022-01-01 2022-12-31 10963006 2023-12-31 10963006 2022-12-31 10963006 c:Director2 2023-01-01 2023-12-31 10963006 d:PlantMachinery 2023-01-01 2023-12-31 10963006 d:PlantMachinery 2023-12-31 10963006 d:PlantMachinery 2022-12-31 10963006 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 10963006 d:MotorVehicles 2023-01-01 2023-12-31 10963006 d:MotorVehicles 2023-12-31 10963006 d:MotorVehicles 2022-12-31 10963006 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 10963006 d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 10963006 d:CurrentFinancialInstruments 2023-12-31 10963006 d:CurrentFinancialInstruments 2022-12-31 10963006 d:Non-currentFinancialInstruments 2023-12-31 10963006 d:Non-currentFinancialInstruments 2022-12-31 10963006 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 10963006 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 10963006 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 10963006 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 10963006 d:ShareCapital 2023-12-31 10963006 d:ShareCapital 2022-12-31 10963006 d:RetainedEarningsAccumulatedLosses 2023-12-31 10963006 d:RetainedEarningsAccumulatedLosses 2022-12-31 10963006 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 10963006 d:AcceleratedTaxDepreciationDeferredTax 2022-12-31 10963006 d:TaxLossesCarry-forwardsDeferredTax 2023-12-31 10963006 d:TaxLossesCarry-forwardsDeferredTax 2022-12-31 10963006 d:RetirementBenefitObligationsDeferredTax 2023-12-31 10963006 d:RetirementBenefitObligationsDeferredTax 2022-12-31 10963006 c:FRS102 2023-01-01 2023-12-31 10963006 c:Audited 2023-01-01 2023-12-31 10963006 c:FullAccounts 2023-01-01 2023-12-31 10963006 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 10963006 c:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 10963006 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure
Company registration number: 10963006







FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2023


LAMBOO MEDICAL LTD






































img00a1.png                        

 


LAMBOO MEDICAL LTD
REGISTERED NUMBER:10963006



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
155,962
93,117

  
155,962
93,117

Current assets
  

Stocks
  
33,250
33,250

Debtors: amounts falling due within one year
 5 
462,933
166,317

Cash at bank and in hand
  
24,044
22,684

  
520,227
222,251

Creditors: amounts falling due within one year
 6 
(248,971)
(177,701)

Net current assets
  
 
 
271,256
 
 
44,550

Total assets less current liabilities
  
427,218
137,667

Creditors: amounts falling due after more than one year
 7 
(1,156)
(148,671)

Provisions for liabilities
  

Deferred tax
 9 
(38,516)
-

  
 
 
(38,516)
 
 
-

Net assets/(liabilities)
  
387,546
(11,004)


Capital and reserves
  

Allotted, called and fully paid share capital
  
10,000
10,000

Profit and loss account
  
377,546
(21,004)

  
387,546
(11,004)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
J. M. Lamboo
Director

Page 1

 


LAMBOO MEDICAL LTD
REGISTERED NUMBER:10963006


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2023

Date: 26 June 2024

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

Lamboo Medical Ltd is a private company, limited by shares, registered in England and Wales. The Company's registered number and registered office address can be found on the Company Information page.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.3

Operating lease commitments

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

  
2.4

Revenue

Revenue represents the total invoice value, excluding value added tax, trade discounts and all other taxes of sales made during the year.

Page 3

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

  
2.5

Revenue recognition

Revenue is recognised when goods have been delivered and services supplied to customers such that risks and rewards of ownership have transferred to them.
Revenue from ongoing support contracts is spread over the life of the contract according to the level of costs expected to be incurred as the contract is performed. 

 
2.6

Leased assets: the Company as lessee

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance lease are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to profit or loss so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

  
2.8

Related party exemption

The Company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidaries within the group.

 
2.9

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.10

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.11

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20%
Motor vehicles
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.13

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 5

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.14

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.15

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.


3.


Employees

The average monthly number of employees, including directors, during the year was 13 (2022 - 12).


4.


Tangible fixed assets





Plant and machinery
Motor vehicles
Total

£
£
£



Cost or valuation


At 1 January 2023
79,738
102,927
182,665


Additions
5,755
120,490
126,245


Disposals
-
(21,609)
(21,609)



At 31 December 2023

85,493
201,808
287,301



Depreciation


At 1 January 2023
50,130
39,418
89,548


Charge for the year on owned assets
14,649
38,216
52,865


Disposals
-
(11,074)
(11,074)



At 31 December 2023

64,779
66,560
131,339



Net book value



At 31 December 2023
20,714
135,248
155,962



At 31 December 2022
29,608
63,509
93,117

Page 6

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

5.


Debtors

2023
2022
£
£


Trade debtors
203,591
94,406

Amounts owed by group undertakings
93,638
-

Other debtors
23,861
26,241

Prepayments and accrued income
141,843
40,263

Deferred taxation
-
5,407

462,933
166,317



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
68,802
99,889

Corporation tax
81,670
-

Other taxation and social security
22,461
11,180

Obligations under finance lease and hire purchase contracts
2,776
2,776

Other creditors
1,899
1,824

Accruals and deferred income
71,363
62,032

248,971
177,701


The following liabilities were secured:

2023
2022
£
£



Hire purchase contracts
3,932
6,708

3,932
6,708

Details of security provided:

Amount due under hire purchase contracts are secured against the assets concerned.

Page 7

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

7.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Other loans
-
144,739

Net obligations under finance leases and hire purchase contracts
1,156
3,932

1,156
148,671



8.


Amounts due under non-cancellable operating leases

2023
2022
        £
        £

Within one year

89,877

89,877

Between one and five years

299,592

359,510

More than five years

-

29,959


389,469

479,346



9.


Deferred taxation




2023


£






At beginning of year
5,407


Charged to profit or loss
(43,923)



At end of year
(38,516)

The deferred taxation balance is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(38,991)
(21,883)

Tax losses carried forward
-
27,290

Pension surplus
475
-

(38,516)
5,407

Page 8

 


LAMBOO MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

10.


Controlling party

The immediate and ultimate parent company is Lamboo Medical Holding B.V., a company incorporated in the Netherlands at Koperstraat 44, Zoetermeer, Netherlands. This is the largest and smallest group in which the company's accounts are consolidated. 


11.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2023 was unqualified.

The audit report was signed on 26 June 2024 by A Hookway (Senior statutory auditor) on behalf of Menzies LLP.

 
Page 9